[189 Pages Report] The Animal Health Market size was estimated at USD 83.85 billion in 2023 and expected to reach USD 90.62 billion in 2024, at a CAGR 8.38% to reach USD 147.38 billion by 2030.

Animal health comprises pharmaceuticals, vaccines, and additives that help in the comprehensive well-being and proper functioning of animals, encompassing the prevention, diagnosis, and treatment of diseases and overall physical and mental health maintenance. This field is crucial for ensuring livestock productivity, food supplies' safety, and pets' well-being. The increasing global demand for animal-derived products, such as meat, dairy, and eggs, necessitates the maintenance of healthy livestock populations, driving the demand for animal health products. Additionally, growing awareness of zoonotic diseases increases the importance of robust animal health practices to prevent public health crises, creating a platform for market growth. The high costs associated with advanced veterinary services, treatments, and technologies hamper the market growth. Rising innovations in veterinary pharmaceuticals and biotechnology that drive the development of new vaccines, diagnostics, and treatments are expected to create opportunities for market growth. The rising adoption of pet insurance that makes advanced veterinary care more accessible to pet owners is anticipated to expand the scope of the animal health market.

In the Americas, the market is driven by a strong focus on livestock production efficiency, pet ownership trends favoring advanced veterinary care, and stringent regulatory standards ensuring product safety and efficacy. In South America, agriculture plays a significant role, with a growing demand for animal health products to support large-scale livestock farming and export-oriented meat production. APAC is a dynamic region with diverse markets and rapid economic growth driving increased demand for animal health products. China and India are major countries, with expansive livestock sectors and rising pet ownership driving growth in veterinary services and pharmaceuticals. In China, modernization of agriculture and food safety concerns are key drivers of the animal health market. Southeast Asian countries, including Thailand and Vietnam, are emerging as important markets due to expanding poultry and aquaculture industries. EMEA represents a highly developing market with established veterinary pharmaceutical industries in countries such as Germany, France, and the UK. Europe emphasizes animal welfare, sustainability, and food safety, driving demand for innovative animal health solutions and environmentally friendly practices. The Middle East and Africa face unique challenges, such as tropical diseases affecting livestock and limited access to veterinary services in rural areas. However, urbanization, increasing disposable incomes, and a growing middle class are boosting demand for companion animal health products and services across the region.

The market dynamics represent an ever-changing landscape of the Animal Health Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Increasing incidences of zoonotic and food-borne diseases
  • Government initiative and support for the adoption of animal welfare
  • Growing rate of pet adoption with increased intervention toward animal health
• Market Restraints
  • Limited availability and acceptance and dearth of veterinarians
• Market Opportunities
  • Accelerating research and development activities for launching new and innovative products
  • Rising availability and adoption of pet insurance
• Market Challenges
  • Restrictions imposed by regulatory authorities on the use of antibiotics

• Product: Growing usage of medicinal feed additives to promote health and prevent diseases

  Biologics include vaccines such as inactivated (killed) vaccines, which use dead microorganisms to stimulate an immune response and are known for their safety and stability, albeit often requiring multiple doses. Another type is the modified or attenuated live vaccines use weakened live microorganisms to mimic actual infections, generating a strong, long-lasting immune response but necessitating careful management. In diagnostics, consumables, reagents, and kits are essential for disease detection, while instruments and devices, such as blood analyzers and imaging tools, facilitate diagnostic procedures. This category includes reusable diagnostic equipment and disposables that ensure hygiene and accuracy. Medical equipment spans several essential tools, including anesthesia equipment for pain-free surgeries, critical care consumables like catheters for intensive care, and fluid management devices crucial for hydration and medication delivery. Patient monitoring equipment tracks vital signs, and rescue and resuscitation tools such as defibrillators are used in emergencies. Additionally, research equipment aids scientific study, and temperature management devices are vital for post-surgery and critical care. Medicinal feed additives are supplements like vitamins and probiotics added to animal feed to enhance health, growth, and disease prevention. Pharmaceuticals comprise analgesics for pain management, anti-infectives that combat bacterial, viral, and fungal infections, anti-inflammatory drugs for reducing pain and improving mobility, and parasiticides that prevent infestations by parasites, including fleas and ticks. These categories collectively play crucial roles in ensuring the well-being of animals.

• End User: Growing adoption of animal health products by veterinarians for the maintenance of animal health and welfare across different settings

  Farmers & ranchers are involved in raising livestock for food, fiber, labor, and other uses. Their primary concern in animal health is maintaining their animals' well-being to ensure productivity and profitability. They require various health products such as vaccines, antibiotics, and nutritional supplements to prevent and treat diseases. Good animal health practices help them to produce high-quality meat, milk, wool, and other animal products while minimizing losses. Pet owners keep animals for companionship and may view them as part of the family. Their focus is on their pets' overall well-being and longevity, including dogs, cats, birds, and other small animals. Pet owners rely on animal health products like preventive medications, treatments for common conditions, and wellness products such as special diets and supplements. Regular visits to veterinarians for check-ups, vaccinations, and treatments are common practices among pet owners. Veterinarians are medical professionals who treat various animals, including household pets, livestock, and, occasionally, wildlife. They play a crucial role in animal health by diagnosing conditions, performing surgeries, administering vaccines, and advising animal owners on optimal care practices. Veterinarians also contribute to public health by managing zoonotic diseases that could transfer from animals to humans. Their expertise and services are essential for maintaining animal health and welfare across different settings. Veterinarians require advanced, reliable solutions as they provide primary care to both pets and livestock. Pet owners look for convenient, preventive, and wellness-oriented products to ensure the longevity and well-being of their animals. Farmers & ranchers focus on productivity, preventive care, and efficient herd management.

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Animal Health Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Animal Health Market.

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Animal Health Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The value chain of the Animal Health Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

The pricing analysis comprehensively evaluates how a product or service is priced within the Animal Health Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Animal Health Market.

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Animal Health Market.

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Animal Health Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

The trade analysis of the Animal Health Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

The regulatory framework analysis for the Animal Health Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Animal Health Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Animal Health Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

• Phibro Animal Health's USD 350 Million Acquisition of Zoetis’ Product Portfolio to Boost Global Reach and Manufacturing Capacity

  Phibro Animal Health Corporation agrees to acquire Zoetis Inc.'s medicated feed additive (MFA) product portfolio, certain water-soluble products, and related assets for USD 350 million. This acquisition significantly expands Phibro's product offerings and global reach, as the portfolio, comprising over 37 product lines, generated approximately USD 400 million in 2023 and is sold in around 80 countries. Completion is expected later this year, potentially leading to increased market presence and production capabilities for Phibro Animal Health Corporation, strategically positioning them for sustained growth. [Published On: 2024-04-29]

• Merck & Co., Inc. Strengthens Aquaculture Presence with Elanco Animal Health Acquisition

  Merck Animal Health, known as MSD Animal Health, has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for USD 1.3 billion in cash. This acquisition includes an innovative portfolio of medicines, vaccines, nutrition, and supplements for aquatic species, alongside two aqua manufacturing facilities in Canada and Vietnam and a research facility in Chile. This deal is expected to be completed by mid-year 2024, pending regulatory approvals and customary closing conditions. This transaction positions Merck Animal Health to enhance its product offerings, expand its aquatic health market presence, and strengthen its long-term strategic growth plans. [Published On: 2024-02-05]

• MSD Animal Health Introduces Falcon Biomass to Revolutionize Fish Farming Efficiency and Welfare

  MSD Animal Health has introduced Falcon Biomass, a solution designed to enhance fish farming operations by optimizing biomass measurement. This innovation aims to address key challenges in the aquaculture industry, improving both efficiency and fish welfare. The launch involves a transaction where fish farmers can access advanced, real-time monitoring technology, which reduces the need for manual measurement and promotes better resource management. Anticipated results include heightened accuracy in biomass estimates, decreased labor costs, and improved fish health. [Published On: 2023-08-22]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Animal Health Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Animal Health Market, highlighting leading vendors and their innovative profiles. These include Heska Corporation, Vetoquinol Group, Randox Laboratories Ltd., Thermo Fisher Scientific, Inc, Ceva Animal Health LLC, IDEXX Laboratories, Inc., HIPRA, S.A., Dechra Pharmaceuticals PLC, bioMerieux SA, Virbac S.A, Merck & Co., Inc., Cadila Healthcare Limited, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Zoetis Inc., Boehringer Ingelheim GmbH, Norbrook Holdings Limited, INDICAL Bioscience GmbH, Covetrus, Inc., and BioChek BV.

This research report categorizes the Animal Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Biologics
    • Vaccine
      • Inactivated (Killed)
      • Modified/ Attenuated Live
  • Diagnostics
    • Consumables, Reagents, & Kits
    • Instruments & Devices
  • Equipment & Disposables
    • Anesthesia Equipment
    • Critical Care Consumables
    • Fluid Management Equipment
    • Patient Monitoring Equipment
    • Rescue & Resuscitation Equipment
    • Research Equipment
    • Temperature Management Equipment
  • Medicinal Feed Additives
  • Pharmaceuticals
    • Analgesics
    • Anti-infectives
    • Anti-inflammatory
    • Parasiticides
• Animal Type
  • Companion Animal
    • Cats
    • Dogs
    • Horses
  • Farm Animal
    • Cattle
    • Poultry
    • Sheep & Goats
    • Swine
• End User
  • Farmers & Ranchers
  • Pet Owners
  • Veterinarians

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?